The leukotriene biosynthetic pathway: a target for pharmacological attack
- 31 December 1986
- journal article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 7, 100-103
- https://doi.org/10.1016/0165-6147(86)90273-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in manNature, 1985
- Leukotrienes in Disease Implications for Drug DevelopmentDrugs, 1985
- Retinoids are potent inhibitors of the generation of rat leukocyte leukotriene B4-like activity in vitroEuropean Journal of Pharmacology, 1984
- Caffeic acid is a selective inhibitor for leukotriene biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984
- Pharmacological profile of AA-861, A 5-lipoxygenase inhibitorProstaglandins, 1983
- PHARMACOLOGY OF LEUKOTRIENESBritish Medical Bulletin, 1983
- Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and InflammationScience, 1983
- Bronchoconstrictor Effects of Leukotriene C in HumansScience, 1982
- Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoidsNature, 1980
- Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytesNature, 1980